ARTICLE | Clinical News
Biovail Corp. International regulatory update
March 8, 1999 8:00 AM UTC
Canada granted marketing approval for BVF's Brexidol piroxicam-beta-cyclodextrin, a non-steroidal anti-inflammatory drug (NSAID) to treat mild to severe acute pain. BVF's Crystaal division will marke...